PDB19 THE COST-EFFECTIVENESS OF PIOGLITAZONE COMPARED WITH SITAGLIPTIN- AN ECONOMIC EVALUATION USING A VALIDATED ECONOMIC MODEL FROM ATHIRD PARTY PAYER PERSPECTIVE IN THE USA
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)64967-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)64967-4/fulltext
Section Title :
Section Order :
125
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64967-4&doi=10.1016/S1098-3015(10)64967-4